NO950599L - Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4 - Google Patents

Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4

Info

Publication number
NO950599L
NO950599L NO950599A NO950599A NO950599L NO 950599 L NO950599 L NO 950599L NO 950599 A NO950599 A NO 950599A NO 950599 A NO950599 A NO 950599A NO 950599 L NO950599 L NO 950599L
Authority
NO
Norway
Prior art keywords
pct
hiv replication
inhibiting hiv
sec
date
Prior art date
Application number
NO950599A
Other languages
English (en)
Other versions
NO950599D0 (no
Inventor
Jerome Schwartz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO950599D0 publication Critical patent/NO950599D0/no
Publication of NO950599L publication Critical patent/NO950599L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

En fremgangsmåte for behandling av HIV-infeksjon i en pasient, om- fattende at det til en pasient infisert med HIV administreres en terapeutisk effektiv mengde IL-4.
NO950599A 1992-08-19 1995-02-17 Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4 NO950599L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93213492A 1992-08-19 1992-08-19
PCT/US1993/007587 WO1994004179A1 (en) 1992-08-19 1993-08-17 Method for inhibiting hiv replication using il-4

Publications (2)

Publication Number Publication Date
NO950599D0 NO950599D0 (no) 1995-02-17
NO950599L true NO950599L (no) 1995-02-17

Family

ID=25461831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950599A NO950599L (no) 1992-08-19 1995-02-17 Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4

Country Status (22)

Country Link
US (1) US5700461A (no)
EP (1) EP0656785B1 (no)
JP (1) JP2711182B2 (no)
KR (1) KR950702838A (no)
CN (1) CN1086437A (no)
AT (1) ATE163860T1 (no)
AU (1) AU683427B2 (no)
CA (1) CA2142862C (no)
CZ (1) CZ38095A3 (no)
DE (1) DE69317428T2 (no)
ES (1) ES2113549T3 (no)
FI (1) FI950696A (no)
HU (1) HUT72709A (no)
IL (1) IL106717A0 (no)
MX (1) MX9305016A (no)
NO (1) NO950599L (no)
NZ (1) NZ255735A (no)
PL (1) PL307508A1 (no)
SK (1) SK21295A3 (no)
TW (1) TW291439B (no)
WO (1) WO1994004179A1 (no)
ZA (1) ZA936018B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0858343B1 (en) 1995-11-02 2004-03-31 Schering Corporation Continuous low-dose cytokine infusion therapy
US20040132161A1 (en) * 1998-04-20 2004-07-08 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US20050124645A1 (en) * 1998-04-20 2005-06-09 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US20030232738A1 (en) * 1998-04-20 2003-12-18 National Jewish Medical And Research Center Method and composition for increasing CD4+ T lymphocyte immune responsiveness
CA2335617C (en) * 1998-06-24 2009-12-15 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US6734192B1 (en) 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
JPH02485A (ja) * 1987-08-03 1990-01-05 Yuu Honshiyo 新規なヒトインターロイキン４、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
CA2078676A1 (en) * 1990-03-21 1991-09-22 Jerome Schwartz Use of il-4 to enhance immune response to infectious antigenic challenges
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
EP0490006B1 (en) * 1990-12-13 1994-06-22 Schering-Plough Pharmaceutical compositions for the treatment of B-cell malignancies

Also Published As

Publication number Publication date
NZ255735A (en) 1997-06-24
KR950702838A (ko) 1995-08-23
ES2113549T3 (es) 1998-05-01
FI950696A0 (fi) 1995-02-16
HUT72709A (en) 1996-05-28
US5700461A (en) 1997-12-23
WO1994004179A1 (en) 1994-03-03
PL307508A1 (en) 1995-05-29
CZ38095A3 (en) 1995-12-13
IL106717A0 (en) 1993-12-08
NO950599D0 (no) 1995-02-17
JPH07506116A (ja) 1995-07-06
AU5007593A (en) 1994-03-15
HU9500487D0 (en) 1995-04-28
EP0656785B1 (en) 1998-03-11
CA2142862A1 (en) 1994-03-03
DE69317428D1 (de) 1998-04-16
EP0656785A1 (en) 1995-06-14
MX9305016A (es) 1994-02-28
CA2142862C (en) 2000-05-30
ZA936018B (en) 1994-06-13
TW291439B (no) 1996-11-21
SK21295A3 (en) 1997-01-08
CN1086437A (zh) 1994-05-11
FI950696A (fi) 1995-02-16
AU683427B2 (en) 1997-11-13
ATE163860T1 (de) 1998-03-15
JP2711182B2 (ja) 1998-02-10
DE69317428T2 (de) 1998-07-02

Similar Documents

Publication Publication Date Title
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ES2150022T3 (es) Aerosol farmaceutico que contiene al menos un azucar.
DK0751766T3 (da) Nasal og okular indgivelse af ketamin til behandling af smerter og til afgiftning
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE59401401D1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
AU4923093A (en) Inhibitors of metazoan parasite proteases
NO950599D0 (no) Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4
TW261532B (no)
AU1081695A (en) The use of an ester of inositoltrisphosphate for the preparing of medicaments
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
DK0586589T3 (da) Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
EE03385B1 (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
SE9504267D0 (sv) New therapeutic use
GB9507883D0 (en) Compounds
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
GB9310049D0 (en) Growth factor effects